Australian people can buy antibiotics in Australia online here: http://buyantibioticsaustralia.com/ No prescription required and cheap price!

Material safety data sheet

Synonyms: Salt; Rock Salt; Saline; Table Salt
CAS No.: 7647-14-5
Molecular Weight: 58.44
Chemical Formula: NaCl
Manufacturer/Supplier:
Globe Chemicals GmbH Spohrstr. 2 D-22083 Hamburg Deutschland 2. Composition/Information on Ingredients Ingredient CAS No Percent Hazardous --------------------------------------- ------------ ------------ --------- Sodium Chloride 7647-14-5 99 - 100% Yes Emergency Overview
--------------------------
WARNING! CAUSES EYE IRRITATION.
SAF-T-DATA(tm) Ratings (Provided here for your convenience)
-----------------------------------------------------------------------------------------------
------------
Health Rating: 1 - Slight
Flammability Rating: 0 - None
Reactivity Rating: 0 - None
Contact Rating: 1 - Slight
Lab Protective Equip: GOGGLES; LAB COAT; PROPER GLOVES
Storage Color Code: Green (General Storage)
-----------------------------------------------------------------------------------------------
------------
Potential Health Effects
----------------------------------
Inhalation:
May cause mild irritation to the respiratory tract.
Ingestion:
Very large doses can cause vomiting, diarrhea, and prostration. Dehydration
and congestion occur in most internal organs. Hypertonic salt solutions can
produce violent inflammatory reactions in the gastrointestinal tract.
Skin Contact:
May irritate damaged skin; absorption can occur with effects similar to those
via ingestion.
Eye Contact:
Causes irritation, redness, and pain. (For salt concentrations greater than the
normal saline present.)
Chronic Exposure:
No information found.
Aggravation of Pre-existing Conditions:
No information found.
Inhalation:
Remove to fresh air. Get medical attention for any breathing difficulty.
Ingestion:
If large amounts were swallowed, give water to drink and get medical advice.
Skin Contact:
Wash exposed area with soap and water. Get medical advice if irritation
develops.
Eye Contact:
Immediately flush eyes with plenty of water for at least 15 minutes, lifting
upper and lower eyelids occasionally. Get medical attention if irritation
persists.
Fire:
Not considered to be a fire hazard.
Explosion:
Not considered to be an explosion hazard.
Fire Extinguishing Media:
Use any means suitable for extinguishing surrounding fire.
Special Information:
In the event of a fire, wear full protective clothing and NIOSH-approved self-contained breathing apparatus with full facepiece operated in the pressure demand or other positive pressure mode. Ventilate area of leak or spill. Wear appropriate personal protective equipment as specified in Section 8. Spills: Sweep up and containerize for reclamation or disposal. Vacuuming or wet sweeping may be used to avoid dust dispersal. Small amounts of residue may be flushed to sewer with plenty of water. Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against physical damage. Containers of this material may be hazardous when empty since they retain product residues (dust, solids); observe all warnings and precautions listed for the product. 8. Exposure Controls/Personal Protection Airborne Exposure Limits:
None established.
Ventilation System:
In general, dilution ventilation is a satisfactory health hazard control for this
substance. However, if conditions of use create discomfort to the worker, a
local exhaust system should be considered.
Personal Respirators (NIOSH Approved):
For conditions of use where exposure to dust or mist is apparent and
engineering controls are not feasible, a particulate respirator (NIOSH type N95
or better filters) may be worn. If oil particles (e.g. lubricants, cutting fluids,
glycerine, etc.) are present, use a NIOSH type R or P filter. For emergencies or
instances where the exposure levels are not known, use a full-face positive-
pressure, air-supplied respirator. WARNING: Air-purifying respirators do not
protect workers in oxygen-deficient atmospheres.
Skin Protection:
Wear protective gloves and clean body-covering clothing.
Eye Protection:
Use chemical safety goggles. Maintain eye wash fountain and quick-drench
facilities in work area.
Appearance:
White crystals.
Odor:
Odorless.
Solubility:
36g/100cc water @ 20C (68F)
Specific Gravity:
2.16
pH:
6.7 - 7.3 (aqueous solution)
% Volatiles by volume @ 21C (70F):
0
Boiling Point:
1413C (2575F)
Melting Point:
801C (1474F)
Vapor Density (Air=1):
No information found.
Vapor Pressure (mm Hg):
1.0 @ 865C (1589F)
Evaporation Rate (BuAc=1):
No information found.
Stability:
Stable under ordinary conditions of use and storage. Hygroscopic.
Hazardous Decomposition Products:
When heated to above 801C (1474F) it emits toxic fumes of chloride and
sodium oxide.
Hazardous Polymerization:
Will not occur.
Incompatibilities:
Lithium, bromine trifluoride.
Conditions to Avoid:
Incompatibles.
Oral rat LD50: 3000 mg/kg. Inhalation rat LC50: > 42 gm/m3 /1H. Skin rabbit LD50: > 10 gm/kg. Investigated as a mutagen, reproductive effector. --------\Cancer Lists\------------------------------------------------------ ---NTP Carcinogen--- Ingredient Known Anticipated IARC Category ------------------------------------ ----- ----------- ------------- Sodium Chloride (7647-14-5) No No None Environmental Fate:
No information found.
Environmental Toxicity:
No information found.
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved waste disposal facility. Processing, use or contamination of this product may change the waste management options. State and local disposal regulations may differ from federal disposal regulations. Dispose of container and unused contents in accordance with federal, state and local requirements. --------\Chemical Inventory Status - Part 1\--------------------------------- Ingredient TSCA EC Japan Australia ----------------------------------------------- ---- --- ----- --------- Sodium Chloride (7647-14-5) Yes Yes Yes Yes --------\Chemical Inventory Status - Part 2\--------------------------------- --Canada-- Ingredient Korea DSL NDSL Phil. ----------------------------------------------- ----- --- ---- ----- Sodium Chloride (7647-14-5) Yes Yes No Yes --------\Federal, State & International Regulations - Part 1\---------------- -SARA 302- ------SARA 313------ Ingredient RQ TPQ List Chemical Catg. ----------------------------------------- --- ----- ---- -------------- Sodium Chloride (7647-14-5) No No No No --------\Federal, State & International Regulations - Part 2\---------------- -RCRA- -TSCA- Ingredient CERCLA 261.33 8(d) ----------------------------------------- ------ ------ ------ Sodium Chloride (7647-14-5) No No No Chemical Weapons Convention: No TSCA 12(b): No CDTA: No SARA 311/312: Acute: Yes Chronic: No Fire: No Pressure: No Reactivity: No (Pure / Solid)
Australian Hazchem Code: None allocated.
Poison Schedule: None allocated.
WHMIS:
This MSDS has been prepared according to the hazard criteria of the
Controlled Products Regulations (CPR) and the MSDS contains all of the
information required by the CPR.
NFPA Ratings: Health: 1 Flammability: 0 Reactivity: 0
Label Hazard Warning:
WARNING! CAUSES EYE IRRITATION.
Label Precautions:
Avoid contact with eyes.
Wash thoroughly after handling.
Label First Aid:
In case of eye contact, immediately flush eyes with plenty of water for at least
15 minutes. Get medical attention if irritation develops or persists.
Product Use:
Laboratory Reagent.
Revision Information:
No Changes.
Disclaimer:
***************************************************************
*********************************

Source: http://www.cadilhac.ma/cariboost_files/sodium_20chloride_20phar_fds_.pdf

Clinical pharmacogenetic laboratory request form

CLINICAL PHARMACOGENETIC LABORATORY REQUEST FORM Information about Diet Patient's Habits 1. THERAPEUTIC DRUG MONITORING (TDM) Number Name of Molecule Expected Number of Days to Achieve Therapeautic Range Steady State (Css) 1. Alprazolam 2. Amisulpiride 3. Amitriptyline+Nortriptyline 4. Aripiprazole Dehidroaripiprazole 5. Bupropion(under inves

Drug side effects

AMBULATORY SURGERY CENTER OF SPARTANBURG, LLC SIDE EFFECT MEDICATION INFORMATION – ORIGINAL COPY TO PATIENT Below you will find information regarding medications you have received during your procedure today. Side effects and special instructions are listed. It is important that you understand the effects of these drugs may last up to 24 hours following their administration. During such

Copyright © 2010-2014 Find Medical Article